Two routes are not one measurement
Material may cross the intestinal epithelium through cells or between them. Transcellular transport depends on cellular uptake and transport processes. Paracellular passage occurs through the intercellular space and is regulated in part by junctional complexes. A method that is informative about one route does not automatically characterize the other.
This distinction prevents the term intestinal permeability from becoming an undefined summary label. Every permeability claim should identify the route or construct being examined, the material or marker used, and the biological conditions under which passage was assessed.
Dynamic junctional organization
Tight junctions are often described as seals, but a permanent seal is a poor physiological model. Junctional structures participate in regulated paracellular passage and can respond to biological signalling. Reversible modulation is therefore compatible with normal regulation; it is not by itself evidence of pathological disruption.
The relevant question is not whether a junction is simply open or closed. It is how junctional organization changes, what signal is involved, whether the change is transient or sustained, and whether measured passage has biological consequences in that model or population.
Expression, structure and function
Measurements of junction-associated gene expression, protein abundance, microscopic localization and functional passage answer different questions. Transcriptomic change indicates altered RNA-level activity within a tissue or cell population. It does not, on its own, demonstrate altered protein organization or functional permeability.
Likewise, an observed structural difference can be biologically informative without establishing the amount, route or clinical significance of passage. Strong interpretation triangulates molecular, structural and functional outcomes instead of treating any one of them as a complete description of the barrier.
Mechanistic pathways and whole-barrier interpretation
The zonulin literature provides one mechanistic example of reversible junctional modulation. It supports investigation of a regulated paracellular pathway. It does not justify equating zonulin, tight junctions and the entire intestinal barrier.
Whole-barrier function also involves transcellular transport, mucus, epithelial viability, immune activity and microbial context. A pathway-level observation should remain at pathway level unless additional measurements connect it to broader functional outcomes.
What the evidence supports
Mechanistic and synthesis literature supports tight junctions as regulated contributors to paracellular permeability.
It supports separating transcellular from paracellular routes and separating molecular expression from measured function.
What remains uncertain
The current sources do not establish a universal molecular signature of clinically important junctional dysregulation.
No single junction-associated measure can be treated as a complete or diagnostic measure of intestinal barrier function.
References
- König J, Wells J, Cani PD, et al. Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol 2016;7(10):e196. doi:10.1038/ctg.2016.54. DOI
- Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016;4(4):e1251384. doi:10.1080/21688370.2016.1251384. DOI
- Tripathi A, Lammers KM, Goldblum S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A 2009;106(39):16799–16804. doi:10.1073/pnas.0906773106. DOI